Patient
SITE008-0072
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE008 (KOR) (Dr. Kim)
consented 2025-11-29
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-11-30 (study day 182); relationship: RELATED
Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2022-10-16 (study day 137); relationship: NOT RELATED
Grade 2 Vomiting — outcome: RECOVERED/RESOLVED; onset 2022-09-19 (study day 110); relationship: not assessed
Grade 3 Constipation — outcome: RECOVERED/RESOLVED; onset 2022-07-24 (study day 53); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.